Aging services groups call for federal plan to end ‘national nightmare’ of COVID-19… Hot spot Florida’s governor ready to resume visits for long-term care facilities … Texas releases additional...
Researchers: Key to living long is in genes
By
Haymarket Media
Aug 30, 2007
Living to 100 may hinge on having special genes that balance out the harmful effects of other, “bad” genes, researchers say. Their discovery could lead to the development of medications aimed...
Smith & Nephew launches negative pressure wound care system
Feb 24, 2009
Smith & Nephew’s Advanced Wound Management division recently announced the U.S. launch of its new Renasys EZ negative pressure wound therapy system. The new product will enable clinicians to exercise...
Clinical briefs for Thursday, March 17
By
Alicia Lasek
Mar 17, 2022
FDA to host public workshop addressing gaps in opioid prescriber education content … Frailty in rheumatoid arthritis reversible with treatment and exercise … FDA approves Symbicort aerosol generic...
Diabetes risk impacted more by excess weight than genetics, experts say
By
Alicia Lasek
Sep 01, 2020
Bringing weight below an individualized “trigger” threshold could prevent or even reverse the disease, the results of a new study indicate.
Nursing home faces trailblazing lawsuit over asking workers for family medical histories
By
McKnight's Staff
May 29, 2013
A nursing and rehabilitation center violated federal law by asking for workers’ family medical history, a government lawsuit alleges. The suit is one of the first of its kind.
Clinical Briefs for Friday, December 6
By
Alicia Lasek
Dec 05, 2019
Opinion: FDA’s lax generic drug oversight puts seniors at risk … Study supports non-drug treatment for early diabetes symptoms … Bipartisan bill would create Office of Alzheimer’s Disease in Florida...
Healthy lifestyle may lower dementia risk despite genetics
May 26, 2022
Higher midlife scores in the Life’s Simple 7 lifestyle health risk test are associated with a lower risk for dementia, a new study finds.
Popular Alzheimer’s drug going generic
By
Haymarket Media
Sep 04, 2007
The U.S. Food and Drug Administration has provided tentative approval to Ranbaxy Pharmaceuticals Inc. to make and market the generic version of dementia treatment Razadyne.
FDA places black-box warning on blood thinner Plavix
Mar 15, 2010
The Food and Drug Administration Friday placed a black-box warning—its most severe safety labeling—on the blood thinner Plavix. In a statement, it said that the drug could put certain patients at increased...